Antibody Pharmacokinetic Analysis

Pharmacokinetic (PK) studies are required for evaluating new molecular entities and is an essential prerequisite for interpreting preclinical efficacy and toxicology results.

Pharmacokinetic (PK) studies involve administration of drugs through different routes and samples collection. The plasma-drug concentration at different time points can be measured by ELISA and analyzed for PK data by WinNonlin.

With AAALAC accredited animal room facilities, we provide you with PK assay development and validation in various species, as well as one-stop services for the high-quality antigen/antibody production.

Service Highlights

1. High precision PK solution

  • Four molecular types, five animal species, six drug delivery routes and seven types of biological substrates are available for selection, and high-precision PK solutions can be customized according to molecular characteristics.

2. Standardized Laboratory Animal Facility

  • We have rented SPF/Elite level animal facility, high-quality laboratory mice and meet animal ethics requirements.

3. One-stop high-quality customized service

  • One-stop services from the high-quality antigen/antibody to PK assay development and validation.

4. Fast and high-quality delivery

  • We utilize effective method development, transfer, set-up, and validation techniques to identify and quantitate drug in a timely and cost-effective method.


Popular articles

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more
Shanghai Model Organisms Jinshan R&D Base officially put into operation

After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.

Learn more